Cardiac Troponin Market Size, Share & Industry Analysis, By Type (Troponin T and Troponin I), By Setting (Laboratory Testing and Point-of-Care (POC) Testing), By Indication (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, and Others) By End User (Hospitals & Clinics, Diagnostic Laboratories, and Homecare Settings & Others), and Regional Forecast, 2026-2034

Last Updated: December 22, 2025 | Format: PDF | Report ID: FBI101234

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Cardiovascular Diseases, By Key Countries/Regions, 2024/2025
2. Technological Advancements in Cardiac Troponin Testing
3. New Product Launches. By Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships etc.)
5. Impact of COVID-19 on the Market
Global Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Rest of Europe
Asia Pacific Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Rest of Asia Pacific
Latin America Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. bioMérieux SA
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. Abbott
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. Siemens Healthineers AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. Eurolyser Diagnostica GmbH
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  6. QuidelOrtho (Quidel Corporation)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  7. PerkinElmer Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  8. Beckman Coulter, Inc. (Danaher)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  9. RESPONSE BIOMEDICAL
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  10. LifeSign LLC.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Cardiovascular Diseases, By Key Countries/Regions, 2024/2025
2. Technological Advancements in Cardiac Troponin Testing
3. New Product Launches. By Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships etc.)
5. Impact of COVID-19 on the Market
Global Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Rest of Europe
Asia Pacific Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Rest of Asia Pacific
Latin America Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Cardiac Troponin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Troponin T
  2. Troponin I
2. Market Analysis, Insights and Forecast – By Setting
  1. Laboratory Testing
  2. Point-of-Care (POC) Testing
3. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Homecare Settings & Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. bioMérieux SA
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. Abbott
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. Siemens Healthineers AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. Eurolyser Diagnostica GmbH
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  6. QuidelOrtho (Quidel Corporation)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  7. PerkinElmer Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  8. Beckman Coulter, Inc. (Danaher)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  9. RESPONSE BIOMEDICAL
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  10. LifeSign LLC.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Cardiac Troponin Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Cardiac Troponin Market Value Share (%), By Type, 2025 & 2034

Figure 3: Global Cardiac Troponin Market Value Share (%), by Setting, 2025 & 2034

Figure 4: Global Cardiac Troponin Market Value Share (%), by Indication, 2025 & 2034

Figure 5: Global Cardiac Troponin Market Value Share (%), by End-User, 2025 & 2034

Figure 6: Global Cardiac Troponin Market Value (USD billion), by Region, 2025 & 2034

Figure 7: North America Cardiac Troponin Market Value (USD billion), By Type, 2025 & 2034

Figure 8: North America Cardiac Troponin Market Value Share (%), By Type, 2025

Figure 9: North America Cardiac Troponin Market Value (USD billion), by Setting, 2025 & 2034

Figure 10: North America Cardiac Troponin Market Value Share (%), by Setting, 2025

Figure 11: North America Cardiac Troponin Market Value (USD billion), by Indication, 2025 & 2034

Figure 12: North America Cardiac Troponin Market Value Share (%), by Indication, 2025

Figure 13: North America Cardiac Troponin Market Value (USD billion), by End-User, 2025 & 2034

Figure 14: North America Cardiac Troponin Market Value Share (%), by End-User, 2025

Figure 15: North America Cardiac Troponin Market Value (USD billion), By Country, 2025 & 2034

Figure 16: North America Cardiac Troponin Market Value Share (%), By Country, 2025

Figure 17: Europe Cardiac Troponin Market Value (USD billion), By Type, 2025 & 2034

Figure 18: Europe Cardiac Troponin Market Value Share (%), By Type, 2025

Figure 19: Europe Cardiac Troponin Market Value (USD billion), by Setting, 2025 & 2034

Figure 20: Europe Cardiac Troponin Market Value Share (%), by Setting, 2025

Figure 21: Europe Cardiac Troponin Market Value (USD billion), by Indication, 2025 & 2034

Figure 22: Europe Cardiac Troponin Market Value Share (%), by Indication, 2025

Figure 23: Europe Cardiac Troponin Market Value (USD billion), by End-User, 2025 & 2034

Figure 24: Europe Cardiac Troponin Market Value Share (%), by End-User, 2025

Figure 25: Europe Cardiac Troponin Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 26: Europe Cardiac Troponin Market Value Share (%), By Country/ Sub-region, 2025

Figure 27: Asia Pacific Cardiac Troponin Market Value (USD billion), By Type, 2025 & 2034

Figure 28: Asia Pacific Cardiac Troponin Market Value Share (%), By Type, 2025

Figure 29: Asia Pacific Cardiac Troponin Market Value (USD billion), by Setting, 2025 & 2034

Figure 30: Asia Pacific Cardiac Troponin Market Value Share (%), by Setting, 2025

Figure 31: Asia Pacific Cardiac Troponin Market Value (USD billion), by Indication, 2025 & 2034

Figure 32: Asia Pacific Cardiac Troponin Market Value Share (%), by Indication, 2025

Figure 33: Asia Pacific Cardiac Troponin Market Value (USD billion), by End-User, 2025 & 2034

Figure 34: Asia Pacific Cardiac Troponin Market Value Share (%), by End-User, 2025

Figure 35: Asia Pacific Cardiac Troponin Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 36: Asia Pacific Cardiac Troponin Market Value Share (%), By Country/ Sub-region, 2025

Figure 37: Latin America Cardiac Troponin Market Value (USD billion), By Type, 2025 & 2034

Figure 38: Latin America Cardiac Troponin Market Value Share (%), By Type, 2025

Figure 39: Latin America Cardiac Troponin Market Value (USD billion), by Setting, 2025 & 2034

Figure 40: Latin America Cardiac Troponin Market Value Share (%), by Setting, 2025

Figure 41: Latin America Cardiac Troponin Market Value (USD billion), by Indication, 2025 & 2034

Figure 42: Latin America Cardiac Troponin Market Value Share (%), by Indication, 2025

Figure 43: Latin America Cardiac Troponin Market Value (USD billion), by End-User, 2025 & 2034

Figure 44: Latin America Cardiac Troponin Market Value Share (%), by End-User, 2025

Figure 45: Latin America Cardiac Troponin Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 46: Latin America Cardiac Troponin Market Value Share (%), By Country/ Sub-region, 2025

Figure 47: Middle East & Africa Cardiac Troponin Market Value (USD billion), By Type, 2025 & 2034

Figure 48: Middle East & Africa Cardiac Troponin Market Value Share (%), By Type, 2025

Figure 49: Middle East & Africa Cardiac Troponin Market Value (USD billion), by Setting, 2025 & 2034

Figure 50: Middle East & Africa Cardiac Troponin Market Value Share (%), by Setting, 2025

Figure 51: Middle East & Africa Cardiac Troponin Market Value (USD billion), by Indication, 2025 & 2034

Figure 52: Middle East & Africa Cardiac Troponin Market Value Share (%), by Indication, 2025

Figure 53: Middle East & Africa Cardiac Troponin Market Value (USD billion), by End-User, 2025 & 2034

Figure 54: Middle East & Africa Cardiac Troponin Market Value Share (%), by End-User, 2025

Figure 55: Middle East & Africa Cardiac Troponin Market Value (USD billion), By Country/ Sub-region, 2025 & 2034s

Figure 56: Middle East & Africa Cardiac Troponin Market Value Share (%), By Country/ Sub-region, 2025

Figure 57: Global Cardiac Troponin Market Share (%), By Company, 2025

List of Tables

Table 1: Global Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 2: Global Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2021–2034

Table 3: Global Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 4: Global Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2021–2034

Table 5: Global Cardiac Troponin Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 6: North America Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 7: North America Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2021-2034

Table 8: North America Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 9: North America Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2021-2034

Table 10: North America Cardiac Troponin Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 11: Europe Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 12: Europe Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2021-2034

Table 13: Europe Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 14: Europe Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2021-2034

Table 15: Europe Cardiac Troponin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 16: Asia Pacific Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 17: Asia Pacific Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2021-2034

Table 18: Asia Pacific Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 19: Asia Pacific Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2021-2034

Table 20: Asia Pacific Cardiac Troponin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 21: Latin America Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 22: Latin America Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2021-2034

Table 23: Latin America Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 24: Latin America Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2021-2034

Table 25: Latin America Cardiac Troponin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 26: Middle East & Africa Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 27: Middle East & Africa Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2021-2034

Table 28: Middle East & Africa Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2021-2034

Table 29: Middle East & Africa Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2021-2034

Table 30: Middle East & Africa Cardiac Troponin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 150

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com